The investigators hypothesize that continuous infusion of 4 µg/Kg/day T4 with 30 µg/Kg/day
oral potassium iodide (KI) for 42 days from birth will reduce by 30% or more (from an
estimated 30% to 21%) the proportion of extremely low gestational age subjects with a
composite endpoint of "cerebral palsy (CP) or a Bayley III Composite Cognitive Score < 85" at
36 months corrected postnatal age (CA).
Phase:
Phase 3
Details
Lead Sponsor:
New York Medical College
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)